102 related articles for article (PubMed ID: 17346677)
1. HER-2/neu raises SHP-2, stops IFN-gamma anti-proliferation in bladder cancer.
Su WP; Tu IH; Hu SW; Yeh HH; Shieh DB; Chen TY; Su WC
Biochem Biophys Res Commun; 2007 Apr; 356(1):181-6. PubMed ID: 17346677
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells.
Kominsky SL; Hobeika AC; Lake FA; Torres BA; Johnson HM
Cancer Res; 2000 Jul; 60(14):3904-8. PubMed ID: 10919667
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
4. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
Bai T; Luoh SW
Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
[TBL] [Abstract][Full Text] [Related]
5. The role of protein tyrosine phosphatase SHP-1 in the regulation of IFN-gamma signaling in neural cells.
Massa PT; Wu C
J Immunol; 1996 Dec; 157(11):5139-44. PubMed ID: 8943425
[TBL] [Abstract][Full Text] [Related]
6. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia.
Kim HY; Park EJ; Joe EH; Jou I
J Immunol; 2003 Dec; 171(11):6072-9. PubMed ID: 14634121
[TBL] [Abstract][Full Text] [Related]
7. HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
Coogan CL; Estrada CR; Kapur S; Bloom KJ
Urology; 2004 Apr; 63(4):786-90. PubMed ID: 15072912
[TBL] [Abstract][Full Text] [Related]
8. Immune complexes suppress IFN-gamma signaling by activation of the FcgammaRI pathway.
Boekhoudt GH; Frazier-Jessen MR; Feldman GM
J Leukoc Biol; 2007 Apr; 81(4):1086-92. PubMed ID: 17227821
[TBL] [Abstract][Full Text] [Related]
9. The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals.
Steiner E; Holzmann K; Pirker C; Elbling L; Micksche M; Sutterlüty H; Berger W
J Cell Sci; 2006 Feb; 119(Pt 3):459-69. PubMed ID: 16418217
[TBL] [Abstract][Full Text] [Related]
10. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
Hsu MC; Chang HC; Hung WC
Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
[TBL] [Abstract][Full Text] [Related]
11. Deferoxamine enhances anti-proliferative effect of interferon-gamma against hepatocellular carcinoma cells.
Okada T; Sawada T; Kubota K
Cancer Lett; 2007 Apr; 248(1):24-31. PubMed ID: 16837131
[TBL] [Abstract][Full Text] [Related]
12. TRAIL expression up-regulated by interferon-gamma via phosphorylation of STAT1 induces myeloma cell death.
Miura Y; Tsujioka T; Nishimura Y; Sakaguchi H; Maeda M; Hayashi H; Dong M; Hyodoh F; Yata K; Wada H; Sugihara T; Otsuki T
Anticancer Res; 2006; 26(6B):4115-24. PubMed ID: 17201122
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells.
Lin MF; Lee MS; Zhou XW; Andressen JC; Meng TC; Johansson SL; West WW; Taylor RJ; Anderson JR; Lin FF
J Urol; 2001 Nov; 166(5):1943-50. PubMed ID: 11586265
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of HER-2/neu oncogene and transitional cell carcinoma of bladder.
Jalali Nadoushan MR; Taheri T; Jouian N; Zaeri F
Urol J; 2007; 4(3):151-4. PubMed ID: 17987577
[TBL] [Abstract][Full Text] [Related]
15. Basic science of HER-2/neu: a review.
Hung MC; Lau YK
Semin Oncol; 1999 Aug; 26(4 Suppl 12):51-9. PubMed ID: 10482194
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
Chakraborty A; Guha S
Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
[TBL] [Abstract][Full Text] [Related]
18. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells.
Lynch RA; Etchin J; Battle TE; Frank DA
Cancer Res; 2007 Feb; 67(3):1254-61. PubMed ID: 17283162
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression.
Wong LL; Chang CF; Koay ES; Zhang D
Int J Oncol; 2009 May; 34(5):1291-301. PubMed ID: 19360341
[TBL] [Abstract][Full Text] [Related]
20. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Leung KC; Brce J; Doyle N; Lee HJ; Leong GM; Sjögren K; Ho KK
Endocrinology; 2007 May; 148(5):2417-23. PubMed ID: 17272397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
